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  16 
Summary  17 
The peptidoglycan (PG) cell wall is a major protective external sheath in bacteria and a key 18 
target for antibiotics1. PG is present in virtually all bacteria, suggesting that it has a very 19 
ancient origin, and was likely present in the last bacterial common ancestor2. Cell wall 20 
expansion is orchestrated by cytoskeletal proteins related to actin (MreB) and tubulin (FtsZ)3, 21 
which also emerged very early in evolution. FtsZ has been characterised in a wide range of 22 
organisms and is a key essential player in a highly organised division machine that directs an 23 
invaginating annulus of cell wall PG, together with the other various cell envelope layers. 24 
MreB plays an analogous role in directing growth of the lateral wall in cylindrical (rod shaped) 25 
organisms, which comprise the majority of extant bacterial forms. Recent work on cell wall-26 
less derived bacteria, called L-forms, has revealed that these cells require neither MreB nor 27 
FtsZ for growth and division4-6, consistent with the notion that these proteins are concerned 28 
exclusively with wall dynamics. Discovery that ftsZ can be deleted in an L-form background 29 
recently provided, for the first time, a means of generating an ftsZ null mutant of E. coli. 30 
Remarkably, starting with this strain we have been able to isolate variants of E. coli that lack 31 
FtsZ but are capable of efficient growth in a walled state. Genetic analysis reveals that a 32 
combination of three mutations is needed for this phenotype. Importantly, the suppressive 33 
mutations lead to a major cell shape change, from the normal cylindrical shape to a branched 34 
and bulging, ramified shape, which we call “coli-flower”. The results highlight the versatility 35 
and adaptability of bacterial cells and illustrate possible evolutionary routes leading to the 36 
emergence of specialised bacteria such as pathogenic Chlamydia or aquatic Planctomycetes, 37 
that lack FtsZ but retain the PG cell wall7-9. 38 
  39 
Results and discussions 40 
Cell wall-free bacteria, also called L-forms, can regenerate their parental cell 41 
morphology in the absence of a pre-existing template6,10. In E. coli, the recovery of a walled 42 
rod-shaped morphology from a pleiomorphic L-form requires only a few cell division 43 
events11,12. Here, we investigated the requirement of cell division events in the recovery 44 
process using an E. coli L-form strain lacking the essential cell division ftsZ gene (Fig. 1a). 45 
As previously observed, when wild-type E. coli L-forms were cultured in the absence of a cell 46 
wall inhibitor, but presence of an osmotic stabiliser, the cells readily resumed growth and 47 
reverted to the rod-shaped walled state (Fig. 1b, top panels)6,11,12. In contrast, L-forms of the 48 
ftsZ deleted strain failed to grow under these conditions (Fig. 1b, bottom left panel). 49 
Microscopic observation revealed the presence of non-dividing filamentous cells in the ftsZ-50 
deleted strain (Fig. 1b, bottom right panel), showing that the cells are capable of resuming 51 
normal rod-shaped growth in the absence of a functional division apparatus, even though 52 
they cannot sustain long term proliferation.  53 
Unexpectedly, after prolonged incubation of a plate bearing an ftsZ-deleted strain, 54 
several colonies appeared, presumably containing cell variants capable of growth 55 
(Supplementary Fig. 1a). After confirming that the colonies were variants of the original strain 56 
rather than contaminants, we tested their properties and found that they were of two general 57 
classes. One class had resumed growth as L-forms, presumably by acquiring mutations that 58 
block cell wall synthesis, and these were not studied further. The second class of mutants 59 
(CFL; coli-flower), however, appeared to comprise walled cells, and several lines of evidence 60 
suggested that these were mutants capable of walled growth in the absence of FtsZ. First, 61 
unlike L-forms, the CFL mutants were able to grow in either the absence or the presence of 62 
osmotic stabilisers (Supplementary Fig. 1b and 1c, right and left panels), although 63 
magnesium was needed to stabilise the CFL cells (Supplementary Fig. 1b-c, middle and right 64 
panels, and 1e-f, Supplementary video 1). Second, the CFL mutants grew in liquid media 65 
(Supplementary Fig. 1d), while E. coli L-forms are unable to proliferate under these 66 
conditions6. Finally, in contrast to L-forms, the CFL mutant strains were highly sensitive to β-67 
lactam antibiotics (Fig. 1c, Supplementary Fig. 1g). 68 
In previous reports of experiments with FtsZ impaired strains, the cells were shown to 69 
continue to elongate normally for a few generation times, forming filamentous cells with 70 
approximately normal diameter (Fig. 1b, bottom right panel) but eventually all of the filaments 71 
lysed, with no long-term survivors (e.g.13). However, the CFL mutant cells turned out not to 72 
be filamentous but instead had a bulging, branching and highly pleiotropic morphology, which 73 
we call “coli-flower” (Fig. 1d). Typically, the cells tend to have several peripheral spherical 74 
areas, of differing size, connected to a central branched zone, which sometimes has a more 75 
or less cylindrical shape but with varying width. Interestingly, despite the pleiotropy of cell 76 
morphology, DNA staining revealed a relatively homogeneous distribution of chromosomal 77 
DNA in the cell, both in the branching and spherical areas (Supplementary Fig. 2). 78 
Remarkably, when we reintroduced the ftsZ gene into a CFL mutant strain an almost normal 79 
rod shaped cell morphology was returned (Fig. 1e, Supplementary Fig. 3a-d), revealing that 80 
none of the putative ftsZ-suppressing mutations are required to maintain the wild type cell 81 
shape. Batch cultures of the CFL mutants showed a biphasic growth pattern, with a mass 82 
doubling time of about 60 min in exponential phase (Fig. 1f and Supplementary Fig. 4e), 83 
comparable to isogenic FtsZ+ strains (58 min) (Fig. 1f and Supplementary Fig. 4d). Moreover, 84 
measurement of the viable cell count (colony forming units; CFU) revealed that the cells are 85 
capable of reasonably efficient proliferation (Fig. 1g). 86 
 Time-lapse imaging was used to elucidate the formation of “coli-flower” like cells and 87 
how they divide. In the examples shown (Fig. 2a-c and Supplementary Videos 2-5) a more or 88 
less round cell expanded in two main directions to generate two new spherical areas 89 
connected by a newly formed branch (Fig. 2a, 17 to 85 min and Supplementary Video 1). 90 
Further blebs emerged from the original branch zone, leading in turn to the formation of 91 
additional new-branched spherical areas (Fig. 2a, stars and Supplementary Videos 2-3). 92 
Expansion of the spherical areas seemed to coincide with a reduction of material in the 93 
central zone, leading to an area with extensive narrow ramifications (Fig. 2a and 94 
Supplementary Videos 2-3). Remarkably, despite the absence of an ftsZ-based division 95 
machine, separation-like events frequently occurred (Fig. 2 Arrows and Supplementary 96 
Videos 2-4-5). These events were observed both in branching areas (Fig. 2a, 279 min, 2b, 97 
28-35 min and 2c, 35-45 min and 70-85 min) and at the neck of globular areas, generating 98 
more or less spherical progeny cells (Fig. 2b, 20-25 min and 2c, 55-70 min). 99 
 Whole genome sequencing of three independent ftsZ-less mutant strains revealed the 100 
presence of multiple differences to the parental strain (Supplementary Table 1). These 101 
mutations seemed to be of three main classes. First, all of the mutants had an inactivating 102 
mutation in either the gene (mrcB), for the bi-functional Penicillin Binding Protein 1B (PBP1B) 103 
or for its essential extracellular regulator LpoB14,15. PBP1B is partially redundant to PBP1A 104 
and is thought mainly to be concerned with wall synthesis during cell division15,16. Secondly, 105 
two of the mutants had (different) mutations in the gene lpp, which encodes the major 106 
lipoprotein Lpp (Braun's lipoprotein), which physically connects the outer-membrane to the 107 
peptidoglycan17. One of these mutations would delete the last four amino acids of the Lpp 108 
protein, including the Lysine that is essential for attachment to the peptidoglycan 109 
(Supplementary Table 1). Finally, all three of the mutants had diverse mutations affecting the 110 
synthesis of various extracellular polysaccharides: lipopolysaccharide, the Enterobacterial 111 
Common Antigen (ECA) or colanic acid (Supplementary Table 1). 112 
 To test which of these mutations were needed for the switch to the CFL mode of 113 
growth, we carried out genetic reconstruction experiments in which null mutations in the 114 
various genes were introduced into a ∆ftsZ strain carrying a plasmid pOU82-ftsZ+ that 115 
enables normal growth and division in the walled state. The cells were further engineered so 116 
that this plasmid could be eliminated by addition of IPTG (see Methods). As a control, IPTG 117 
was added to one of the original ftsZ-less walled mutant strains (∆ftsZsup5, bearing mrcB 118 
and lpp mutations) carrying the plasmid pOU82-ftsZ. The strain readily lost the plasmid 119 
(which carries a lacZ gene), as shown by the emergence of white colonies on X-gal plates 120 
(Lac-; Fig. 3a) and loss of the ftsZ gene was confirmed by multiplex PCR (Supplementary Fig. 121 
4a, line 1). In contrast, reconstructed strains bearing ∆ftsZ and either ∆lpoB or ∆lpp, showed 122 
prolonged retention of the ftsZ plasmid (Fig. 3a, ∆ftsZ/∆lpp and ∆ftsZ/∆lpoB; Supplementary 123 
Fig. 4a, lanes 2 and 3). Phase contrast microscopy revealed that depletion of ftsZ in either 124 
∆lpoB or ∆lpp mutants led to the formation of filamentous cells but not CFL-like cells (Fig. 3a). 125 
In contrast, a strain bearing both ∆lpp and ∆lpoB deletions readily lost the plasmid (Fig. 3a, 126 
∆ftsZ/∆lpp/∆lpoB; Supplementary Fig. 4a lane 4). Examination of its morphology revealed a 127 
CFL phenotype similar to that of the original suppressed ftsZ strains (Fig. 3a, lower left and 128 
right panels), thus revealing that combined disruption of the lpoB and lpp genes is sufficient 129 
to enable walled cells to tolerate loss of ftsZ by switching into the CFL mode of proliferation, 130 
although secondary mutations frequently arise that then enable more robust growth 131 
(Supplementary Data 1 and Fig. 4c-d). This effect was specific for the lpoB/PBP1B pathway 132 
because in reconstructed strains containing ∆ftsZ ∆lpp and deletions in the related 133 
lpoA/PBP1A pathway15 loss of the ftsZ plasmid was not permitted (Supplementary Fig. 4b),  134 
 In the above reconstruction experiments it is important to note that the switch to the 135 
CFL state occurred in walled cells without going through an L-form intermediate. We also 136 
tested the genetic requirements for CFL growth starting from the L-form ∆ftsZ state. In 137 
accordance with the above results, when L-forms bearing ∆ftsZ and either ∆lpoB or ∆mrcB 138 
(PBP1B) were streaked in the absence of a cell wall inhibitor (no phosphomycin), but 139 
presence of an osmotic stabiliser, colonies appeared with high efficiency (Fig. 3b), 140 
suggesting an efficient conversion to the CFL state. In contrast, virtually no colonies 141 
appeared from L-forms bearing ∆ftsZ only or ∆ftsZ and either ∆lpoA or ∆mrcA. The strain 142 
bearing ∆ftsZ and ∆lpp, gave an intermediate result, suggesting that, unlike lpoB/mrcB, 143 
mutation of lpp is not sufficient to enable an efficient L-form to CFL transition and perhaps 144 
the acquisition of a secondary mutation is required (Fig. 3b).  145 
 To further investigate the role of these mutations (i.e. lpoB, lpp and colanic acid) in 146 
CFL growth, we introduced plasmids bearing arabinose-inducible lpoB, mrcB, lpp or wcaJ 147 
genes into either one of the spontaneously selected mutants (∆ftsZsup5, bearing mrcB, lpp 148 
and wcaJ mutations) or the reconstructed strain containing deletions in ftsZ, lpp and lpoB 149 
(∆ftsZ/∆lpp/∆lpoBsup). Addition of the inducer, arabinose, had no major effect on growth or 150 
morphology for strains carrying inducible wcaJ or lpp genes (Supplementary Data 2 and Fig. 151 
5). However, induction of lpoB, in the strain ∆ftsZ/∆lpp/∆lpoBsup, and mrcB, in the strain 152 
∆ftsZsup5, abolished growth (Fig. 4a, +lpoB and 4c, +mrcB). (Expression of lpoB in an 153 
isogenic ftsZ+ strain had no effect; Supplementary Fig. 6a). Phase contrast and time-lapse 154 
imaging of cells in the absence of inducer revealed the expected branching and bulging 155 
pattern of growth (Supplementary Fig. 6b and Video 6). However, the lpoB or mrcB induced 156 
cells behaved in a strikingly different manner, reverting slowly to a rod-shaped morphology, 157 
and then forming elongated filamentous cells that did not divide (Fig. 4b, d and e, 158 
Supplementary Video 7), similar to an ftsZ depleted, otherwise wild type strain. Thus, our 159 
results show that loss of PBP1B synthesis or activity is required for the CFL mode of cell 160 
growth but that lpp or wcaJ lesions are less or not important. Additionally, we also showed 161 
that the cell wall elongation system is required for CFL growth (Supplementary Data 3 and 162 
Fig. 7). 163 
To our knowledge, this is the first report of growth and viability of a walled E. coli ftsZ 164 
null mutant, after 35 or so years of study. It seems likely that several labs will have had the 165 
need or opportunity to attempt to generate such mutants but because effective suppression 166 
in the walled state requires two or more independent mutations, the frequency at which 167 
viable mutants would occur would normally be extremely low. Our ability to isolate such a 168 
mutant emerged by studying L-form (wall-free) bacteria, which use a Z-ring-independent 169 
means of proliferation4,6. This illustrates the power of the L-form system for studying the 170 
fundamental processes of cell wall synthesis and cell division.  171 
We have also not been able to find previous reports of the strange CFL cell 172 
morphology. The dramatic morphological transition requires inactivation of both FtsZ and 173 
PBP1B. The lethality that occurs when lpoB or mrcB are reactivated in CFL strains (Fig. 4) 174 
appears to be associated with reversion to a more regular rod-shaped morphology. We 175 
suppose that the relatively constant cell diameter associated with rod-shaped growth is 176 
incompatible with the ability of ftsZ deficient cells to divide. Indeed, CFL cells seem to 177 
undergo division at deeply pinched sites either in narrow tubes or at the junctions between 178 
bulbous cell structures. If so, the role of the PBP1B lesion would be to block the cylindrical 179 
extending mode of cell growth, and or enable the bulging, branching mode of growth. The 180 
efficiency of CFL growth and transition into this state seems to be sensitive to the presence 181 
of a range of additional mutations, including lpp and various extracellular polymers. Further 182 
work will be needed to dissect the roles of these factors. 183 
Although lacking the normal cell division machinery, these E. coli ftsZ-less mutants 184 
divide efficiently (Fig. 1f-g), suggesting the existence of an effective mode of cell-cell 185 
separation in absence of ftsZ. The vast majority of known bacteria seem to rely on the FtsZ-186 
based division machinery for proliferation and, usually, for viability. However, there are 187 
striking examples among both pathogens (e.g. chlamydia) and free-living bacteria (e.g. 188 
Planctomyces), that have dispensed with FtsZ. Phylogenetic trees suggest strongly that 189 
these organism are descended from bacteria that once possessed FtsZ. Our results 190 
demonstrate that only one or two mutations are needed to enable a dramatic evolutionary 191 
switch from dependence to independence of the Z ring machine and highlight the 192 
extraordinary evolutionary adaptability of the bacteria. 193 
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Figure Legends 247 
Figure 1: Isolation and characterisation of walled Escherichia coli ftsZ-less strains 248 
a, Summary of the morphological transitions described in the paper. 249 
b, Cell wall reversion of E. coli L-form strains wild type (TB28, top left) and RM349 (∆ftsZ, 250 
bottom left), following removal of the PG precursor synthesis inhibitor fosfomycin. Cells were 251 
cultured on L-form-supporting medium (NA + MSM) plates (left). Representative phase 252 
contrast images (right) show cell wall reverted E. coli wild type (top) and RM349 (bottom) 253 
cells after 12h incubation. 254 
c, Growth of the strain ∆ftsZsup5 on NA+ 20 mM Mg2+ plates with or without 10 μg/ml of 255 
Ampicillin, as indicated. 256 
d, Phase contrast microscopy of cells of three independent ∆ftsZsup strains grown in NB 257 
with 20 mM Mg2+. 258 
e, Phase contrast microscopy of the ∆ftsZsup5 cells grown in NB with 20 mM Mg2+, after 259 
reintroduction of the plasmid pOU82-ftsZ. 260 
f, Growth profile of the strain ∆ftsZsup5, in presence (blue) or absence (red) of the plasmid 261 
pOU82-ftsZ, in NB with Mg2+. The mass doubling time calculated for the strain ∆ftsZsup5 is 262 
about 58 min in presence and 60 min in the absence of FtsZ. 263 
g, Colony-forming units of the strain ∆ftsZsup5, grown in the presence (blue) or absence 264 
(red) of the plasmid pOU82-ftsZ, corresponding to the growth profile from f. 265 
Scale bars, 3 μm. 266 
 267 
Figure 2: Time lapse imaging of a CFL strain grown in the complete absence of FtsZ 268 
a-c, E. coli ∆ftsZsup strains grown in NB with 20 mM Mg2+ were observed by time-lapse 269 
phase contrast microscopy. Elapsed time (min) is shown in each panel. Scale bars, 3 μm. 270 
Stars identify blebs emerging from the original branch zone and arrows point to division 271 
events. 272 
 273 
Figure 3: PBP1B activity inactivation is required for the transition to a CFL mode of 274 
proliferation in the absence of FtsZ 275 
a, ftsZ loss assays (top) of RM446 (∆ftsZsup5), RM411 (∆ftsZ/∆lpoB), RM413 (∆ftsZ/∆lpp) 276 
and RM419 (∆ftsZ/∆lpp/∆lpoB) strains, containing the plasmids pOU82-ftsZ and pKG339. 277 
Walled cells were streaked on NA plates with 20mM Mg2+, Tetracycline, IPTG and Xgal. The 278 
loss of ftsZ results in the formation of white colonies, which was verified by multiplex PCR 279 
(Supplementary Fig 4a). Corresponding cell morphologies (bottom) of the different streaked 280 
strains were imaged by phase contrast microscopy.  281 
b, Cell wall reversion of E. coli L-form strains RM349 (∆ftsZ), RM411 (∆ftsZ/∆lpoB), RM451 282 
(∆ftsZ/∆mrcB), RM413 (∆ftsZ/∆lpp), RM453 (∆ftsZ/∆lpoA) and RM452 (∆ftsZ/∆mrcA) lacking 283 
pOU82-ftsZ, following removal of the PG precursor synthesis inhibitor fosfomycin. Cells were 284 
cultured on L-form-supporting medium (NA + MSM) plates. 285 
 286 
Figure 4: PBP1B activity inhibits CFL proliferation by restoration of cylindrical cell 287 
shape morphology in the absence of FtsZ 288 
a, Growth of the strain RM445 (∆ftsZ/∆lpp/∆lpoBsup), carrying the plasmid pBAD33-lpoB, 289 
streaked on NA + 20 mM Mg2+ plates in absence (left) or presence (right) of the inducer for 290 
lpoB expression (Arabinose). 291 
b, Phase contrast microscopy of RM445 (∆ftsZ/∆lpp/∆lpoBsup) pBAD33-lpoB cells from b in 292 
the presence of arabinose. 293 
c, Growth of the strain RM362 (∆ftsZsup5), carrying the plasmid pBAD33-mrcB, streaked on 294 
NA + 20 mM Mg2+ plates in absence (left) or presence (right) of the inducer for mrcB 295 
expression inducer (Arabinose).  296 
d, Phase contrast microscopy of RM362 cells (∆ftsZsup5), carrying pBAD33-mrcB from c in 297 
the presence of arabinose. 298 
e, Strain RM445 (∆ftsZ/∆lpp/∆lpoBsup), carrying the plasmid pBAD33-lpoB, grown on 299 
NA/Mg2+ with arabinose, was observed by time-lapse phase contrast microscopy. Elapsed 300 
time (min) is shown in each panel.  301 
Scale bars, 3 μm. 302 
 303 
Methods 304 
Bacterial strains, plasmids and growth conditions 305 
The bacterial strains and plasmids constructs used in this study are shown in Supplementary 306 
Table 3. DNA manipulations, E. coli DH5α transformation and P1 phage transduction were 307 
carried out using standard methods18. Briefly, the plasmid pOU82-Cm-ftsZ was constructed 308 
by insertion, by the Lambda Red recombinase system19, of the chloramphenicol cassette 309 
from pKD3 into pOU82-Amp-ftsZ. The plasmids pBAD33-lpp, pBAD33-wcaJ and pBAD33-310 
mrcB were constructed by insertion of the coding sequences of the lpp, wcaJ and mrcB 311 
genes into pBAD33 digested by the restriction enzymes KpnI and HindIII or XbaI. The 312 
plasmid pBAD24-lpp was constructed by insertion of the coding sequence of the lpp into 313 
pBAD24 digested by the restriction enzymes EcoRI and HindIII. E. coli L-forms were 314 
prepared and grown, as previously described6, in osmoprotective medium composed of 2 x 315 
MSM media pH 7 (40 mM MgCl2, 1 M sucrose and 40 mM maleic acid) mixed 1:1 with 2 x 316 
NBA (Nutrient Broth with 2% Agar (Oxoid)) in presence of fosfomycin (FOS) at 0.4 mg/ml. E. 317 
coli CFL mutant strains were firstly selected on MSM/NBA and then further cultured on 318 
Nutrient Broth (NB, Oxoid) or Nutrient Broth 1% Agar in the presence of 20 mM MgCl2. 319 
Unless specified, the various E. coli strains are incubated at 30°C. When necessary, 320 
antibiotics and supplements were added to media at the following concentrations: ampicillin, 321 
10 or 100 μg/ml; mecillinam, 5 μg/ml; aztreonam, 0.05 μg/ml; A22 (sigma), 10 μg/ml 322 
chloramphenicol, 25 μg/ml; kanamycin, 25 μg/ml; tetracycline, 10 μg/ml; spectinomycin, 50 323 
μg/ml; MgCl2, various concentrations; arabinose, 0.2 %; glucose, 0,5%; Sodium Dodecyl 324 
Sulfate (SDS), 0,5%; IPTG, 1 mg/ml and X-gal, 4%. 325 
 326 
Plasmid pOU82-ftsZ loss assay 327 
Various E. coli strains bearing the plasmid pOU82-ftsZ were transformed with the plasmid 328 
pKG33920 and plated on NA with tetracycline at 30°C for 3 days. Strains carrying both 329 
plasmids were streaked on NA plates with 20mM Mg2+, Tetracycline, IPTG and X-gal and 330 
incubated at 30°C for 3-4 days. White colonies were streaked on NA plates with 20 mM Mg2+ 331 
and X-gal.  332 
Transformation of E. coli ftsZ-less strains 333 
A 1 ml sample of an overnight culture of an E. coli CFL strain was suspended in 200 μl of 334 
TSB, containing 20 % glycerol, 10 % PEG (MW 3350), 5 % DMSO, 10 mM Mgcl2, 10 mM 335 
MgSO4 in NB. A plasmid of interest was added and incubated on ice for 30 min. After heat 336 
shock at 37°C for 5 min, 1 ml of NB with 20 mM Mgcl2 was added and the sample was 337 
incubated for 30 min at 30°C. The sample was plated on NB 1% Agar with 20 mM Mgcl2 and 338 
the appropriate antibiotic and incubated at 30°C. 339 
Multiplex PCR 340 
Mutiplex PCR was performed as described by6. Briefly, E. coli genomic DNA was purified 341 
using a standard phenol-chloroform extraction protocol. The primers were designed using 342 
MPprimer software21 and the recommended procedure was used for the PCR reaction. 343 
Genome sequencing and SNPs identification 344 
Whole genome sequencing was performed with the Illumina HiSeq 2000 System (GATC-345 
Biotech, Germany). Sequencing samples were prepared using a standard chloroform/phenol 346 
extraction procedure. Sequence reads were aligned with CLC Workbench (CLC Bio-Qiagen, 347 
Aarhus, Denmark) software using the NCBI E. coli MG1655 genome (GenBank: U00096.3) 348 
as reference. SNPs and deletion/insertion were also analysed with the CLC Workbench 349 
software. 350 
Microscopy and image analysis  351 
For snap-shot and time-lapse microscopy, exponentially growing cultures of the different CFL 352 
walled strains were mounted and sealed on microscope slides covered with a thin film of 1% 353 
agarose, in NB containing 20mM magnesium. Antibiotics, DAPI and arabinose were added in 354 
the agar pad, as necessary. The cells were imaged for snap-shot microscopy on a Zeiss 355 
Axiovert 200M (Zeiss ×100 Plan-Neofluar oil immersion objective) microscope, and for time-356 
lapse microscopy, on a Nikon Eclipse Ti (Nikon × 100 Plan Fluor oil immersion objective) 357 
contained in a temperature control chamber at 30°C. Images were acquired with Metamorph 358 
6 (Molecular Devices). Pictures and movies were prepared for publication using ImageJ 359 
(http://rsb.info.nih.gov/ij) and Adobe Photoshop. 360 
 361 
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Supplementary Data 3 
Supplementary Data 1: Spontaneous mutations arise in CFL selective conditions 4 
It appears that secondary mutations frequently arise in CFL selective conditions, presumably 5 
to improve the efficiency of growth. We sequenced a variant of the ∆ftsZ/∆lpp/∆lpoB strain 6 
that showed improved growth, giving a mass doubling time of 60 min, similar to that of the 7 
original ftsZsup strains (Supplementary Fig. 4c-d, ∆ftsZ/∆lpp/∆lpoBsup). As for the original 8 
CFL mutants, we found a mutation affecting colanic acid synthesis (truncation of the wzxC 9 
and wcaJ genes; Supplementary Table 2). It therefore seems that synthesis of colanic acid 10 
directly or indirectly impairs the growth of these complex suppressed strains, for reasons that 11 
we have not yet determined. It is interesting to note that colanic acid is normally made under 12 
stress conditions 1 and that mutations affecting colanic acid synthesis have been found in at 13 
least one well characterised L-form strain 2. 14 
 15 
Supplementary Data 2: Effects of the overexpression of Lpp in the ∆ftsZ/∆lpp/∆lpoBsup 16 
strain on SDS sensitivity and on CFL proliferation 17 
We firstly tested if the levels of lpp expression from plasmids pBAD33 (pACYC184) or 18 
pBAD24 (pBR322) were sufficient to complement the known sensitivity of an lpp mutant to 19 
SDS (Supplementary Fig 5a). As shown in Supplementary Fig 5b, in the presence of the lpp 20 
inducer arabinose the plasmid pBAD24-lpp, but not pBAD33-lpp, can complement the 21 
sensitivity to 0.5% SDS of the ∆ftsZ/∆lpp/∆lpoBsup (FtsZ+) strain, suggesting that the level 22 
of lpp expression from pBAD24 was sufficient to complement an lpp mutation. We have 23 
secondly transformed both plasmids, pBAD33-lpp and pBAD24-lpp, into the CFL (FtsZ-) 24 
∆ftsZsup5 and/or ∆ftsZ/∆lpp/∆lpoBsup strains. As shown in Supplementary Fig 5c to h, no 25 
effect on CFL growth or morphology was observed upon induction of lpp expression 26 
(Arabinose). 27 
 28 
Supplementary Data 3: Cell wall elongation system is required for CFL growth 29 
We anticipated that the cell wall elongation system would be required for CFL growth, 30 
and indeed, as shown in Supplementary Fig 7a-b (right panels), inhibition of MreB or PBP2 31 
function with specifically targeted antibiotics (A22 and mecillinam, respectively) blocked CFL 32 
proliferation. Controls showed that growth inhibition by these antibiotics could be restored by 33 
overexpression of ftsQAZ (ftsZup), as described previously 3. Finally, we also tested 34 
inhibition of PBP3 activity. Surprisingly, given that this protein is part of the ftsZ-dependent 35 
division machinery 4, this resulted in loss of CFL proliferation (Supplementary Fig. 7c), for 36 
reasons that are not yet clear. 37 
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 64 
Supplementary Figure 1: Characterisation of walled E. coli ftsZ-less strains 65 
a, Cell wall reversion of E. coli L-form strain RM349 (∆ftsZ), upon removal of the PG 66 
precursor synthesis inhibitor fosfomycin, on L-form-supporting medium (NA + MSM) plates 67 
after two weeks at 30°C. 68 
b-c, Growth of the strain ∆ftsZsup1 (b) and ∆ftsZsup5 (c) streaked on L-form-supporting 69 
medium (NA + MSM, left) or NA in the absence (no Mg2+, middle) or presence (20 mM Mg2+, 70 
right) of 20 mM magnesium. 71 
d, Growth profile of the strain ∆ftsZsup5 in NB in the presence (red, NB2+) or absence (blue, 72 
NB) of 20 mM Mg2+. 73 
e, Growth of the strain ∆ftsZsup5 streaked on NA plates with various concentration of Mg2+. 74 
f, Growth of the strain ∆ftsZsup5 (left panels) and ∆ftsZsup5*, magnesium dependant 75 
suppressor (right panels) streaked on NA plates in absence (0 mM) or presence (10 mM) of 76 
10 mM magnesium. 77 
g, Growth of the strain wild type TB28 streaked on NA + 20 mM Mg2+ plates with 78 
(NA2+/Ampicillin) or without (NA2+) 10 μg/ml of Ampicillin. 79 
 80 
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 95 
Supplementary Figure 2: Nucleoid localisation in an E. coli ftsZ-less strain 96 
Phase contrast (Phase, left) and fluorescence (DAPI, middle) microscopy of ∆ftsZsup5 cells 97 
grown in NB with Mg2+ and stained with DAPI. Overlay (right) represents the merge of phase 98 
and fluorescent images. Scale bar, 3 μm. 99 
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Supplementary Figure 3: Growth and cell morphology after reintroduction of ftsZ in an 115 
E. coli ftsZ-less strain. 116 
a, Growth of the strain ∆ftsZsup5, after reintroduction of the plasmid pOU82-ftsZ, streaked 117 
on NA + 20 mM Mg2+ plate, containing X-gal to show the presence of the plasmid. 118 
b, Multiplex PCR of the ftsK, murA, ftsZ and mreC genes from genomic DNA of the E. coli 119 
strains ∆ftsZ pOU82-ftsZ (1), ∆ftsZsup1 (2), ∆ftsZsup5 (3) and ∆ftsZsup5 pOU82-ftsZ (4). M 120 
represents the DNA ladder. 121 
c, Growth of the strain ∆ftsZsup5, streaked on NA with no added magnesium with (right) or 122 
without (left) the plasmid pOU82-ftsZ. 123 
d, Phase contrast microscopy of the ∆ftsZ cells, carrying the plasmid pOU82-ftsZ, grown in 124 
NB with 20 mM Mg2+. Scale bar, 3 μm. 125 
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Supplementary Figure 4: Loss of Lpp and PBP1B activities promotes an ftsZ-less but 146 
walled mode of proliferation. 147 
a, Multiplex PCR of the ftsK, murA, ftsZ and mreC genes from genomic DNA of the E. coli 148 
strains ∆ftsZsup5 (1), ∆ftsZ/∆lpp (2), ∆ftsZ/∆lpoB (3) and ∆ftsZ/∆lpp/∆lpoB (4) obtained from 149 
the plates in Figure 3a. M represents the DNA ladder. 150 
b, ftsZ loss assays of RM119 (∆ftsZ/∆lpp/∆lpoB), RM448 (∆ftsZ/∆lpp/∆mrcB), RM450 151 
(∆ftsZ/∆lpp/∆lpoA), RM449 (∆ftsZ/∆lpp/∆mrcA) strains, containing the plasmids pOU82-ftsZ 152 
and pKG339, streaked on NA containing 20mM Mg2+, Tetracycline, IPTG and Xgal. 153 
c, ftsZ loss assay (top) of RM447 (∆ftsZ/∆lpp/∆lpoBsup) strain, containing the plasmids 154 
pOU82-ftsZ and pKG339, streaked on NA containing 20 mM Mg2+, Tetracycline, IPTG and 155 
Xgal. Corresponding cell morphology (bottom) of the streaked strain was visualised by phase 156 
contrast microscopy. Scale bar, 3 μm. 157 
d, Growth profile of strains RM349 (∆ftsZ pOU82-ftsZ, green) and RM447 158 
(∆ftsZ/∆lpp/∆lpoBsup pOU82-ftsZ, blue) in NB containing 20 mM Mg2+. The mass doubling 159 
times calculated for strains RM349 and RM447 were about 47 and 58 min, respectively.  160 
e, Growth profile of the strain RM445 (∆ftsZ/∆lpp/∆lpoBsup) in NB with 20 mM Mg2+. The 161 
mass doubling time calculated was 60 min. 162 
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Supplementary Figure 5: Lpp or WcaJ activities do not affect CFL proliferation  201 
a, Growth of strains RM349 (∆ftsZ pOU82-ftsZ, top) and RM447 (∆ftsZ/∆lpp/∆lpoBsup pOU82-202 
ftsZ, bottom) streaked on NA + 20 mM Mg2+ in the presence of 0.5% SDS  203 
b, Growth of the strain RM447 (∆ftsZ/∆lpp/∆lpoBsup pOU82-ftsZ), carrying plasmids pBAD33-204 
lpp (left) and pBAD24-lpp (bottom) streaked on NA + 20 mM Mg2+ with 0.5% SDS, and with 205 
lpp expression repressed (glucose, top) or induced (arabinose, bottom). 206 
c-e, Growth of strains RM445 (∆ftsZ/∆lpp/∆lpoBsup), carrying plasmids pBAD33-lpp (c) or 207 
pBAD24-lpp (d) and RM362 (∆ftsZsup5), carrying the plasmid pBAD24-lpp (e), streaked on 208 
NA + 20mM Mg2+ with lpp expression repressed (glucose, left) or induced (arabinose, right). 209 
f-h, Corresponding phase contrast images of RM445 (∆ftsZ/∆lpp/∆lpoBsup) pBAD33-lpp (f), 210 
RM445 (∆ftsZ/∆lpp/∆lpoBsup) pBAD24-lpp (g) and RM362 (∆ftsZsup5) pBAD24-lpp cells from 211 
c-e, respectively, in the presence of inducer (arabinose).  212 
i, Growth of strain RM362 (∆ftsZsup5), carrying the plasmid pBAD33-wcaJ, streaked on NA+ 213 
20 mM Mg2+ with wcaJ expression repressed (glucose) or induced (arabinose). 214 
j, Phase contrast microscopy of RM362 cells (∆ftsZsup5), carrying pBAD33-wcaJ from panel 215 
i in the presence of inducer (arabinose). Scale bar, 3 μm. 216 
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 228 
Supplementary Figure 6: PBP1B activity inhibits CFL proliferation in the absence of 229 
FtsZ 230 
a, Growth of the strain RM445 (∆ftsZ/∆lpp/∆lpoBsup) in presence of pOU82-ftsZ, carrying the 231 
plasmid pBAD33-lpoB, streaked on NA + 20 mM Mg2+ in the absence (left) or presence 232 
(right) of the inducer of lpoB expression (arabinose). 233 
b, Phase contrast microscopy of RM445 cells from Figure 3b in the absence of arabinose. 234 
Scale bar, 3 μm. 235 
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Supplementary Figure 7: Effect of the inhibition of MreB, PBP2 and PBP3 on CFL 261 
proliferation 262 
a, Growth of the strain RM445 (∆ftsZ/∆lpp/∆lpoBsup) carrying plasmids pOU82-ftsZ (FtsZlow, 263 
left), pBS58 (FtsZup, middle) or none (No FtsZ, right), streaked on NA + 20mM Mg2+ in the 264 
absence (top) or presence (bottom) of 10 μg/ml of A22. 265 
b, As a, but with 5 μg/ml of mecillinam in bottom plates. 266 
c, Growth of strain RM445 (∆ftsZ/∆lpp/∆lpoBsup) carrying the plasmid pOU82-ftsZ (with FtsZ, 267 
left panels) or none (No FtsZ, right panels), streaked on NA + 20mM Mg2+ in the absence (0) 268 
or presence (0.05) of 0.05 μg/ml of aztreonam. 269 
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Supplementary Tables 271 
Supplementary Table 1: Genetic variation in ftsZsup strains 272 
  273 
 
 
Base  
Positiona (bp) 
Genetic 
Variation 
Gene name 
(synonym) Type of Mutation Gene function
b 
∆f
ts
Zs
up
1 
105305-106456 Deletion ftsZ Deletion of the gene ftsZ  6 
GTP-binding tubulin-like cell division 
protein 
1161341-
1161903 
Deletion of 
562pb fhuE-hinT 
Deletion of the 
promoter region of 
the operon 
containing lpoB 
lpoB: Outer membrane lipoprotein 
 - activator of PBP1B activity 
2824993 A to G mltB Missense E195G Membrane-bound lytic murein transglycosylase B 
3080013 T to G tktA Nonsense Y541Stop Transketolase I 
3969949 T to G wzzE Missense Y307D 
Enterobacterial Common Antigen 
polysaccharide 
 chain length modulation protein 
∆f
ts
Zs
up
5 
105305-106456 Deletion ftsZ Deletion of the gene ftsZ  6 
GTP-binding tubulin-like cell division 
protein 
165768 C to T mrcB Nonsense 347Stop Penicillin-binding protein 1B (Pbp1B) 
1404427-
1585557 
Deletion of 
181kb abgA-ydeP 
Multiple gene 
deletions  
1757618-
1757619 
Deletion of a 
dinucleotides 
(CC) 
lpp Nonsense 74Stop Murein lipoprotein (Braun's lipoprotein) 
2121458 Deletion of a nucleotide (C) wcaJ Nonsense 53Stop 
Colanic acid biosynthsis UDP-glucose 
lipid  
carrier transferase 
2137438 G to A 
intergenic 
of  
wza-yegH 
n.a  
3802322 T to A waaO (waaI) Missense N246I 
UDP-D-glucose:(glucosyl)LPS 
α-1,3-glucosyltransferase
∆f
ts
Zs
up
7 
105305-106456 Deletion ftsZ Deletion of the gene ftsZ  6 
GTP-binding tubulin-like cell division 
protein 
1162915-
1165932 Deletion of 3kb 
lpoB-
intergenic 
of ycfP-ndh 
Multiple gene 
deletions 
 containing lpoB 
lpoB: Outer membrane lipoprotein  
- activator of PBP1B activity 
1391013-
1589070 
Deletion of 
198kb ycjY-ydeT 
Multiple gene 
deletions 
 (Rac prophage)  
1750679-
1761439 
Deletion of 
11kb ydhX-sufD 
Deletion containing 
the gene lpp 
lpp: Murein lipoprotein (Braun's 
lipoprotein) 
2137438 G to A 
intergenic 
of  
wza-yegH 
n.a  
2202729 T to C yehI Silent Conserved hypothetical protein 
3802322 T to A waaO (waaI) Missense N246I 
UDP-D-glucose:(glucosyl)LPS 
 α-1,3-glucosyltransferase 
3969793 G to T wzzE Nonsense 255Stop 
Enterobacterial Common Antigen 
polysaccharide 
 chain length modulation protein 
aCoordinate is based on NCBI RefSeq NC_000913.3 E. coli MG1655 Genome; bGene function is based on EcoCyc 
Database; Red and Green colors represent genes respectively involved in peptidoglycan and extracellular 
polysaccharides synthesis 
 274 
Supplementary Table 2: Genetic variation in the ∆ftsZ/∆lpp/∆lpoBsup strain 275 
 276 
  277 
 
Base  
Positiona (bp) 
Genetic 
Variation 
Gene name 
(synonym) Type of Mutation Gene function
b  
∆f
ts
Z/
∆lp
p/
∆lp
oB
su
p 
458026 G to A clpX Missense  D201N ATP-dependent serine protease 
105305-106456 Deletion ftsZ Deletion of the gene ftsZ 6 
GTP-binding tubulin-like cell 
division protein 
1162638-
1163279 Deletion lpoB 
Deletion of the gene 
lpoB 7 
Outer membrane lipoprotein - 
activator of PBP1B activity 
1405207-
1589365 
Deletion of 
184kb abgR-ydeT Multiple gene deletions  
1757421-
1757657 Deletion lpp 
Deletion of the gene lpp 
7 
Murein lipoprotein (Braun's 
lipoprotein) 
2120046-
2120848 
Deletion of 
802pb wzxC-wcaJ 
Troncation of wzxC and 
wcaJ genes 
wcaJ: Colanic acid biosynthsis 
UDP-glucose lipid carrier 
transferase  
wzxC: Colanic acid exporter
3811225 C to A 
intergenic 
of  
mutM-
rpmG 
n.a  
3969241 G to T wzzE Nonsense G71Stop 
Enterobacterial Common 
Antigen polysaccharide chain 
length modulation protein 
4022740 C to A tatC Missense  S2Y TAT translocation system subunit 
aCoordinate is based on NCBI RefSeq NC_000913.3 E. coli MG1655 Genome; bGene function is based on EcoCyc 
Database; Green color represents genes involved in extracellular polysaccharides synthesis 
 278 
Supplementary Table 3: Bacterial strains and plasmids used in this study 279 
TB28 MG1655 ∆lacIZYA 5 
RM349 TB28 ∆ftsZ::kan pOU82-Amp-ftsZ 6 
RM361 TB28 ∆ftsZ::kan sup1 This study 
RM362 TB28 ∆ftsZ::kan sup5 This study 
RM363 TB28 ∆ftsZ::kan sup7 This study 
RM380 TB28 ∆lpoB::kan 7 
RM381 TB28 ∆lpp::kan 7 
RM382 TB28 ∆mrcB::kan 7 
RM383 TB28 ∆mrcA::kan 7 
RM384 TB28 ∆lpoA::kan 7 
RM411 TB28 ∆ftsZ ∆lpoB::kan pOU82-Amp-ftsZ This study 
RM413 TB28 ∆ftsZ ∆lpp::kan pOU82-Amp-ftsZ This study 
RM419 TB28 ∆ftsZ ∆lpp ∆lpoB::kan pOU82-Amp-ftsZ This study 
RM445 TB28 ∆ftsZ ∆lpp ∆lpoB::kan sup* This study 
RM446 TB28 ∆ftsZ::kan sup5 pOU82-Amp-ftsZ This study 
RM447 TB28 ∆ftsZ ∆lpp ∆lpoB::kan sup* pOU82-Amp-ftsZ This study 
RM448 TB28 ∆ftsZ ∆lpp ∆mrcB::kan pOU82-Amp-ftsZ This study 
RM449 TB28 ∆ftsZ ∆lpp ∆mrcA::kan pOU82-Amp-ftsZ This study 
RM450 TB28 ∆ftsZ ∆lpp ∆lpoA::kan pOU82-Amp-ftsZ This study 
RM451 TB28 ∆ftsZ ∆mrcB::kan pOU82-Amp-ftsZ This study 
RM452 TB28 ∆ftsZ ∆mrcA::kan pOU82-Amp-ftsZ This study 
RM453 TB28 ∆ftsZ ∆lpoA::kan pOU82-Amp-ftsZ This study 
Plasmid Relevant Genotype Reference/Origin 
pOU82-Amp-
ftsZ R1-replicon, Amp lacZYA ftsZ 6 
pOU82-Cm-ftsZ R1-replicon, Cm lacZYA ftsZ This study 
pBAD33 pACYC184, Cm araC Para Lab Collection 
pBAD33-lpoB pACYC184, Cm araC Para-lpoB 8 
pBAD33-lpp pACYC184, Cm araC Para-lpp This study 
pBAD33-wcaJ pACYC184, Cm araC Para-wcaJ This study 
pBAD33-mrcB pACYC184, Cm araC Para-mrcB This study 
pBAD24-lpp pBR322, Amp araC Para-lpp This study 
pBS58 pGB2, Sp ftsQAZ 9 
pKG339 pSC101, Plac::copA TetR 10 
pKD46-Sp SpR, λ Red recombinase expression 6 
kan, kanamycin;  cat, chloramphenicol; tet,tetracyclin; Amp, b-lactamase; Sp,spectinomycin 
lacZ, b-galactosidase; Para, promoter arabinose; Plac, promoter lactose 
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Supplementary Videos 283 
Supplementary video 1: Time-lapse series showing ∆ftsZsup5 cells growing on NA. Phase 284 
contrast images were acquired automatically every minute for about 87 min. Scale bar is 3 285 
μm. 286 
 287 
Supplementary video 2: Time-lapse series showing ∆ftsZsup1 cell growing on NA 20mM 288 
Mg2+, from which the panels in Figure 2b were obtained. Phase contrast images were 289 
acquired automatically every minute for about 279 min. Scale bar is 3 μm. 290 
 291 
Supplementary video 3: Time-lapse series showing ∆ftsZsup7 cell growing on NA 20mM 292 
Mg2+. Phase contrast images were acquired automatically every minute for about 109 min. 293 
Scale bar is 3 μm. 294 
 295 
Supplementary video 4: Time-lapse series showing ∆ftsZsup7 cell dividing on NA 20mM 296 
Mg2+, from which the panels in Figure 2b were obtained. Phase contrast images were 297 
acquired automatically every minute for about 69 min. Scale bar is 3 μm. 298 
 299 
Supplementary video 5: Time-lapse series showing ∆ftsZsup cell dividing on NA + 20 mM 300 
Mg2+, from which the panels in Figure 2c were obtained. Phase contrast images were 301 
acquired automatically every minute for about 90 min. Scale bar is 3 μm. 302 
 303 
Supplementary video 6: Time-lapse series showing RM445 (∆ftsZ/∆lpp/∆lpoBsup) cell, 304 
bearing the plasmid pBAD33-lpoB cell growing on NA + 20 mM Mg2+ with glucose (lpp 305 
expression repressed). Phase contrast images were acquired automatically every minute for 306 
about 209 min. Scale bar is 3 μm. 307 
 308 
Supplementary video 7: Time-lapse series showing RM445 (∆ftsZ/∆lpp/∆lpoBsup), bearing 309 
the plasmid pBAD33-lpoB cell growing on NA + 20 mM Mg2+ with lpoB expression induced 310 
(arabinose), from which the panels in Figure 3d were obtained. Phase contrast images were 311 
acquired automatically every minute for about 209 min. Scale bar is 3 μm. 312 
 313 
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